Evofem Biosciences (EVFM) Tops Q2 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Evofem Biosciences Reports Second Quarter 2021 Financial Results and Provides Corporate Update
August 11, 2021 4:27 PM EDTSAN DIEGO, Aug. 11, 2021 /PRNewswire/ --Â Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), today reported financial results for the three- and six-month periods ended June 30, 2021.
"We are pleased to show strong and sustainable growth in Phexxi prescriptions and dispensed units in the... More
